Ezetimibe/Simvatastatin (E/S) plus extended reléase niacin (N) in hyperlipidemia (HL) patients with diabetes (DM) or metabolic syndrome (MS)

Authors
Category Primary study
JournalAtherosclerosis Supplements
Year 2009
This article has no abstract
Epistemonikos ID: 3ff10053fa75aee9725b1322d620e70b5be3449b
First added on: Feb 28, 2025